Deep space travel, long celebrated for its potential to expand humanity's reach, may come with a previously unconsidered biological cost. A NASA-funded study published in the FASEB Journal has found that galactic cosmic radiation (GCR) — the high-energy particles that bombard spacecraft beyond Earth's protective magnetic field — can inflict lasting damage to erectile tissues in male rats, with effects that linger more than a year after exposure.
The research, conducted at NASA's Space Radiation Laboratory in New York, subjected 86 male rats to four weeks of simulated space conditions. The animals were anesthetized and held in harnesses at 30-degree angles to mimic microgravity while being exposed to varying doses of radiation designed to replicate GCR. Even the lowest exposure levels triggered oxidative stress, which damaged the artery that supplies blood to the penis and the surrounding erectile tissue. Notably, these effects persisted for over a year, suggesting a long-term impact that could complicate extended missions.
Why This Matters for Crewed Missions
The findings add a new layer to the known health risks of deep space exploration, which already include muscle atrophy, bone density loss, and increased cancer risk from radiation. The study's authors describe the discovery as exposing "a new health risk to consider with deep space exploration," a concern that becomes more pressing as agencies like NASA plan for crewed missions to Mars, which could take several years round-trip.
Justin La Favor, a neurovascular dysfunction expert at Florida State University and the study's senior author, told Newsweek that the result was "not terribly surprising" given prior research. "Prior research has demonstrated that GCR can cause damage to the endothelium and the nervous system," he explained, "both of which are critical for proper erectile function." This dual impact — on blood vessels and nerves — underscores the complexity of the threat.
Weightlessness also contributed to the rats' health issues, though to a lesser degree than radiation. The combination of GCR and microgravity, both unavoidable on long-duration missions, could compound the problem.
A Potential Path to Treatment
Despite the grim outlook, the study offers a glimmer of hope. The researchers found that targeted treatments aimed at the redox and nitric oxide pathways — molecular routes that regulate blood flow — produced functional improvements in the affected rats. La Favor noted in a report covered by The Guardian that "functional improvements induced by acutely targeting the redox and nitric oxide pathways in the tissues suggest that the erectile dysfunction may be treatable."
This avenue of research could eventually lead to countermeasures for astronauts, though the study's authors caution that the work is still in its early stages. The findings are based on an animal model, and as with all such studies, the leap to human application requires further investigation. The researchers emphasize that the results warrant additional study to determine how these effects might translate to the human body and to refine potential therapies.
For now, the study serves as a reminder that the challenges of deep space travel extend beyond engineering and logistics to the fundamental biology of the human body. As agencies push toward longer missions, understanding these hidden risks will be critical to ensuring the health and well-being of future crews.
